Dr. Kirk Dahl, MD

Undersea and Hyperbaric Medicine Eau Claire, WI Male
NPI: 1760440242
Total Payments
$506,142
2024 Payments
$46,213
Companies
3
Transactions
138

Payment Breakdown by Category

Consulting$505,468 (99.9%)
Travel$530.91 (0.1%)
Food & Beverage$142.42 (0.0%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $505,468 132 99.9%
Travel and Lodging $530.91 4 0.1%
Food and Beverage $142.42 2 0.0%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals U.S.A., Inc. $382,533 91 $0 (2024)
Shire North American Group Inc $123,467 45 $0 (2019)
Smith & Nephew, Inc. $142.42 2 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $46,213 15 Takeda Pharmaceuticals U.S.A., Inc. ($46,213)
2023 $27,308 9 Takeda Pharmaceuticals U.S.A., Inc. ($27,308)
2022 $95,345 21 Takeda Pharmaceuticals U.S.A., Inc. ($95,345)
2021 $122,783 24 Takeda Pharmaceuticals U.S.A., Inc. ($122,783)
2020 $90,885 22 Takeda Pharmaceuticals U.S.A., Inc. ($90,885)
2019 $47,599 17 Shire North American Group Inc ($47,599)
2018 $36,803 11 Shire North American Group Inc ($36,720)
2017 $39,207 19 Shire North American Group Inc ($39,148)

All Payment Transactions

138 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
12/09/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,410.00 General
11/13/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,410.00 General
11/13/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $1,705.00 General
10/09/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,410.00 General
09/11/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,410.00 General
08/09/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,410.00 General
07/12/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,410.00 General
07/12/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $1,705.00 General
06/10/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,310.00 General
05/22/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $2,482.50 General
05/10/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,310.00 General
04/17/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,310.00 General
03/11/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,310.00 General
02/14/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,310.00 General
01/17/2024 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,310.00 General
12/15/2023 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,310.00 General
11/10/2023 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,310.00 General
10/09/2023 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,310.00 General
09/13/2023 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,310.00 General
07/14/2023 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,310.00 General
06/14/2023 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,310.00 General
04/07/2023 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,310.00 General
03/22/2023 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $827.50 General
02/08/2023 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,310.00 General
12/07/2022 Takeda Pharmaceuticals U.S.A., Inc. — Consulting Fee Cash or cash equivalent $3,310.00 General
123…6»

About Dr. Kirk Dahl, MD

Dr. Kirk Dahl, MD is a Undersea and Hyperbaric Medicine healthcare provider based in Eau Claire, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760440242.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kirk Dahl, MD has received a total of $506,142 in payments from pharmaceutical and medical device companies, with $46,213 received in 2024. These payments were reported across 138 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($505,468).

Practice Information

  • Specialty Undersea and Hyperbaric Medicine
  • Other Specialties Emergency Medicine
  • Location Eau Claire, WI
  • Active Since 05/03/2006
  • Last Updated 11/01/2010
  • Taxonomy Code 207PE0005X
  • Entity Type Individual
  • NPI Number 1760440242

Products in Payments

  • Santyl (Drug) $59.18

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.